Kenneth Croitoru

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.

Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.

Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.

Journal: Gut

Published: April 26, 2026

Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease.

Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease.

Journal: Redox biology

Published: March 10, 2026

Defining preclinical stages of Crohn's disease by faecal calprotectin and other risk factors: response to letter.

Defining preclinical stages of Crohn's disease by faecal calprotectin and other risk factors: response to letter.

Journal: Gut

Published: January 17, 2026

From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions.

From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventions.

Journal: Gut

Published: December 26, 2025

Vedolizumab treatment outcomes in early versus late Crohn's disease.

Vedolizumab treatment outcomes in early versus late Crohn's disease.

Journal: The lancet. Gastroenterology & hepatology

Published: November 29, 2025

β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort.

β-Glucan and Inulin Estimated Intake Are Associated With Reduced Risk of Crohn's Disease, Improved Gut Barrier and Systemic Inflammation Markers, and Multi-Omic Signatures in a High-Risk Cohort.

Journal: Gastroenterology

Published: October 27, 2025

Real-World Outcomes of Upadacitinib vs Risankizumab Among Anti-Tumor Necrosis Factor-Exposed Patients With Crohn's Disease.

Real-World Outcomes of Upadacitinib vs Risankizumab Among Anti-Tumor Necrosis Factor-Exposed Patients With Crohn's Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 20, 2025

Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.

Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.

Journal: Journal of clinical gastroenterology

Published: September 28, 2025

Interleukin23 Receptor Genetic Variants Associate With Crohn's Disease Risk and Microbiome Changes in Healthy First-Degree Relatives.

Interleukin23 Receptor Genetic Variants Associate With Crohn's Disease Risk and Microbiome Changes in Healthy First-Degree Relatives.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 27, 2025

Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.

Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.

Journal: Gut microbes

Published: September 05, 2025

Prediction and Prevention of Inflammatory Bowel Disease: A Call to Action.

Prediction and Prevention of Inflammatory Bowel Disease: A Call to Action.

Journal: Gastroenterology

Published: July 25, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026